Abstract: An exhaust gas purifying catalyst device, which can have high durability against vibration and high temperatures, can be configured to suppress the peeling of the catalyst layer from the catalyst carrier member during use. Additionally, the metallic catalyst can be easily recovered after use. According to the present disclosure, an exhaust gas purifying catalyst device can comprise a catalyst carrier member on which metallic catalyst for exhaust gas purification can be carried characterized in that the catalyst carrier member can be formed of a sheet-like catalyst carrier made by a wet paper-making method, and that the metallic catalyst can be carried as a catalyst layer on surfaces of the sheet-like catalyst carrier after the sheet-like catalyst carrier has been baked.

Abstract: A catalyst can be manufactured using a method which can include preparing a first aqueous solution including zirconium, filling the pores of the porous alumina with the aqueous solution by a pore-filling method using the capillary phenomenon, forming a zirconia layer in the pores of the porous alumina, preparing a second aqueous solution including noble metals, filling the pores of the porous alumina with the second aqueous solution by a pore-filling method using the capillary phenomenon, and drying and baking the porous alumina to carry the noble metals in the pores of the porous alumina formed with a zirconia layer.

Abstract: An object of the present invention is to provide a catalyst support which can maintain the purifying ability of HC, CO and NO even after being exposed to a high temperature atmosphere such as about 1000° C. for a long term and a method which can easily produce the catalyst support. According to the present invention there is provided a method for producing a catalyst support of porous alumina formed with pores within which magneto-plumbite type complex oxide ((La.

Abstract: There is provided a HBV precore protein having an ability of forming particles, and a means for determining it. A novel HBV precore protein that forms the virus (like) particles of HBV was identified. The present invention provides this novel HBV precore protein. Furthermore, there are provided core-like particles and virus-like particles formed by this HBV precore protein. These virus-like particles can be used for vaccines and therapeutic agents. The present invention also provides a method of determining the HBV precore protein and a method of determining the anti-HBV precore protein antibody.

Abstract: An intake valve of an internal combustion engine includes a valve body and a valve stem extending from a central portion of the valve body. The valve body includes a valve body framework portion and a valve body thick portion provided on an outer side of the valve body framework portion. The valve body framework portion and the valve stem are made of iron material and the valve body thick portion is made of aluminum alloy.

Abstract: A method for treating a virus-containing sample, characterized by treatment of a virus-containing sample with a treatment solution containing (1) an anionic surfactant and (2) an amphoteric surfactant, nonionic surfactant or protein denaturant; a virus assay method using said treating method; a method for treating a virus-containing sample, characterized by treatment of a virus-containing sample with a treatment solution containing (1) a chaotropic ion and (2) an acidifying agent; a virus assay method using said treating method; a virus assay method, characterized in that a virus antigen and a virus antibody are measured based on their binding to their probe in the presence of a surfactant with an alkyl group of 10 or more carbon atoms and a secondary, tertiary or quaternary amine, or a nonionic surfactant, or of both of them; and a monoclonal antibody and a hybridoma producing the same for carrying out said method.

Abstract: Provided are effective and highly safe agents, medicaments and the like for ameliorating various disorders caused by brain hypofunction. Also provided is a preventing or ameliorating agent for brain hypofunction containing N-acetyl-D-mannosamine, a pharmaceutical composition for preventing, ameliorating or treating disorders due to brain hypofunction, containing an effective amount of N-acetyl-D-mannosamine and a pharmaceutically acceptable carrier, and a food comprising N-acetyl-D-mannosamine added thereto.

Abstract: An object of the present invention is to provide a catalyst support which can maintain the purifying ability of HC, CO and NO even after being exposed to a high temperature atmosphere such as about 1000° C. for a long term and a method which can easily produce the catalyst support. According to the present invention there is provided a method for producing a catalyst support of porous alumina formed with pores within which magneto-plumbite type complex oxide ((La.

Abstract: There is provided a HBV precore protein having an ability of forming particles, and a means for determining it. A novel HBV precore protein that forms the virus (like) particles of HBV was identified. The present invention provides this novel HBV precore protein. Furthermore, there are provided core-like particles and virus-like particles formed by this HBV precore protein. These virus-like particles can be used for vaccines and therapeutic agents. The present invention also provides a method of determining the HBV precore protein and a method of determining the anti-HBV precore protein antibody.

Abstract: A method for treating a virus-containing sample, characterized by treatment of a virus-containing sample with a treatment solution containing (1) an anionic surfactant and (2) an amphoteric surfactant, nonionic surfactant or protein denaturant; a virus assay method using said treating method; a method for treating a virus-containing sample, characterized by treatment of a virus-containing sample with a treatment solution containing (1) a chaotropic ion and (2) an acidifying agent; a virus assay method using said treating method; a virus assay method, characterized in that a virus antigen and a virus antibody are measured based on their binding to their probe in the presence of a surfactant with an alkyl group of 10 or more carbon atoms and a secondary, tertiary or quaternary amine, or a nonionic surfactant, or of both of them; and a monoclonal antibody and a hybridoma producing the same for carrying out said method.

Abstract: To measure the methylation degree of a genomic DNA simply and correctly as well as exhaustively, there is provided a method for amplifying a DNA fragment, characterized by comprising the following steps (1) to (5): (1) digesting a sample double-stranded DNA with a first restriction enzyme; (2) adding a double-stranded DNA fragment consisting of a first oligonucleotide and a second oligonucleotide to a restriction enzyme cleavage end of the double-stranded DNA fragment produced in step (1) to obtain a DNA fragment; (3) digesting the DNA fragment obtained in step (2) with a second restriction enzyme; (4) allowing the double-stranded DNA fragment produced in step (3) to coexist with a third oligonucleotide and a fourth oligonucleotide in the presence of a ligase; and (5) heating the double-stranded DNA fragment obtained in step (4), thereby dissociating the double-stranded DNA fragment and then performing a polymerase chain reaction to selectively amplify a DNA fragment having the cleavage end of the first rest

Abstract: There is provided a HBV precore protein having an ability of forming particles, and a means for determining it. A novel HBV precore protein that forms the virus (like) particles of HBV was identified. The present invention provides this novel HBV precore protein. Furthermore, there are provided core-like particles and virus-like particles formed by this HBV precore protein. These virus-like particles can be used for vaccines and therapeutic agents. The present invention also provides a method of determining the HBV precore protein and a method of determining the anti-HBV precore protein antibody.

Abstract: The present invention provides a method of preparing an anti-methylated DNA antibody, comprising a step of administering to an animal an oligodeoxyribonucleotide containing a methylated cytosine(s) and an oligodeoxyribonucleotide containing no methylated cytosine. The antibody prepared by this method is capable of detecting a DNA containing a methylated cytosine(s) in a state close to the state of a biological component.

Abstract: A truncated form hepatitis C virus gene wherein part of the gene region encoding from the core protein to the NS2 protein of hepatitis C virus has been deleted while retaining the translation frame. In particular, the gene according to claim 1 wherein said part of the gene region is present in a region encoding at least the E1 protein and the E2 protein.

Abstract: A Method for detecting hepatitis B virus as well as a kit and a reagent therefor, comprising using a phosphate buffer that specifically binds to hepatitis B virus, for example a monoclonal antibody that specifically binds to a specific site of core-related protein of hepatitis B virus.

Abstract: A Method for detecting hepatitis B virus as well as a kit and a reagent therefor, comprising using a phosphate buffer that specifically binds to hepatitis B virus, for example a monoclonal antibody that specifically binds to a specific site of core-related protein of hepatitis B virus.

Abstract: A method for measurement of the hepatitis C virus (HCV) characterized by measuring HCV core antigen and HCV core antibody by their binding with probes in the presence of an anionic surfactant or a non-ionic surfactant, or both.

Abstract: A cooling structure of a water-cooled two-cycle parallel multicylinder engine includes: an exhaust port in a cylinder block; an air intake port disposed in a crankcase below the exhaust port; a water pump disposed in the crankcase in an opposite side of the exhaust port; a first cooling water passage introducing cooling water discharged from the water pump to a cooling water jacket of a cylinder head; and a second cooling water passage introducing a part of the cooling water discharged from the water pump to a cooling water jacket below the exhaust port, the second cooling water passage being provided in the crankcase.

Abstract: There is provided a HBV precore protein having an ability of forming particles, and a means for determining it. A novel HBV precore protein that forms the virus (like) particles of HBV was identified. The present invention provides this novel HBV precore protein. Furthermore, there are provided core-like particles and virus-like particles formed by this HBV precore protein. These virus-like particles can be used for vaccines and therapeutic agents. The present invention also provides a method of determining the HBV precore protein and a method of determining the anti-HBV precore protein antibody.

Abstract: A Method for detecting hepatitis B virus as well as a kit and a reagent therefor, comprising using a phosphate buffer that specifically binds to hepatitis B virus, for example a monoclonal antibody that specifically binds to a specific site of core-related protein of hepatitis B virus.